Clinical trials
Bacterial Infections trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 6 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Unknown status | 9 |
| Recruiting | 4 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wyeth is now a wholly owned subsidiary of Pfizer | 3 |
| CanSino Biologics Inc. | 2 |
| Qilu Hospital of Shandong University | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2 |
| Aridis Pharmaceuticals, Inc. | 1 |
| Bayer | 1 |
| Beijing YouAn Hospital | 1 |
| Changchun GeneScience Pharmaceutical Co., Ltd. | 1 |
| Children's Hospital of Fudan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bacterial Infections | 32 |
| Virus Diseases | 4 |
| Pneumonia | 3 |
| Sepsis | 3 |
| Cellulitis | 2 |
| Fibrosis | 2 |
| Liver Cirrhosis | 2 |
| Mycoses | 2 |
| Pneumococcal Infections | 2 |
| Respiratory Tract Infections | 2 |
Trials
Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.